EP Wealth Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-58,593
Closed -$11.2M 445
2019
Q4
$11.2M Sell
58,593
-1,333
-2% -$240K 0.46% 48
2019
Q3
$10.1M Sell
59,926
-255
-0.4% -$41.5K 0.5% 49
2019
Q2
$10.1M Buy
60,181
+4,655
+8% +$645K 0.63% 36
2019
Q1
$8.13M Buy
55,526
+17,789
+47% +$2.58M 0.78% 40
2018
Q4
$5.04M Sell
37,737
-13,719
-27% -$2.25M 0.39% 52
2018
Q3
$9.8M Buy
51,456
+1,899
+4% +$349K 0.77% 39
2018
Q2
$8.26M Buy
49,557
+5,727
+13% +$919K 0.78% 37
2018
Q1
$7.38M Buy
43,830
+14,101
+47% +$2.37M 0.71% 40
2017
Q4
$4.86M Sell
29,729
-1,139
-4% -$204K 0.51% 41
2017
Q3
$6.33M Buy
+30,868
New +$7.18M 0.73% 38
2015
Q2
Sell
-1,376
Closed -$410K 135
2015
Q1
$410K Buy
+1,376
New +$392K 0.08% 78

Other funds holding AGN

EP Wealth Advisors's AGN Position: Q1 2020 in Review

EP Wealth Advisors sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 58,593 shares — an estimated $11.2M sold.

EP Wealth Advisors first reported a position in AGN in Q1 2015 and held it in 11 quarters. The position peaked at $11.2M in Q4 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • EP Wealth Advisors reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • EP Wealth Advisors sold 58,593 Allergan plc shares in Q1 2020, an estimated $11.2M.
  • EP Wealth Advisors first reported a position in Allergan plc in Q1 2015 and held it in 11 quarters.
  • EP Wealth Advisors's Allergan plc position peaked at $11.2M in Q4 2019.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on EP Wealth Advisors's 13F filing for Q1 2020, filed 18 May 2020.